Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.
Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.
(Cantab) Natural Sciences - Double First Class Honours
Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction
Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010
Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010
Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)
July 2nd 2021
January 7th 2021
November 4th 2020
Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.
She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).
In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.